Effect of BDNF val66met polymorphism on declarative memory and its neural substrate: A meta-analysis

Neuroscience and Biobehavioral Reviews

Volumn 36, Issue 9, 2012, Pages 2165-2177

  Kambeitz, Joseph P ^a,b   Bhattacharyya, Sagnik ^a   Kambeitz Ilankovic, Lana M ^a,b   Valli, Isabel ^a   Collier, David A ^a   McGuire, Philip ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

BDNF; Brain derived neurotrophic factor; Declarative memory; Hippocampal volume; Hippocampus; MRI

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; METHIONINE; VALINE;

BDNF GENE; BIPOLAR DISORDER; BRAIN SIZE; COGNITIVE DEFECT; DECLARATIVE MEMORY; DEPRESSION; GENE; GENETIC VARIABILITY; HETEROZYGOTE; HIPPOCAMPUS; HUMAN; MENTAL DISEASE; MENTAL PERFORMANCE; META ANALYSIS (TOPIC); PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; BRAIN-DERIVED NEUROTROPHIC FACTOR; GENOTYPE; HIPPOCAMPUS; HUMANS; MEMORY; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84865984531     PISSN: 01497634     EISSN: 18737528     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2012.07.002     Document Type: Review

References (110)

1. Agartz I., Sedvall G.C., Terenius L., Kulle B., Frigessi A., Hall H., Jönsson E.G. BDNF gene variants and brain morphology in schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2006, 141B:513-523.
2. Aleman A., Hijman R., de Haan E.H., Kahn R.S. Memory impairment in schizophrenia: a meta-analysis. American Journal of Psychiatry 1999, 156:1358-1366.
3. Baig B.J., Whalley H.C., Hall J., McIntosh A.M., Job D.E., Cunningham-Owens D.G., Johnstone E.C., Lawrie S.M. Functional magnetic resonance imaging of BDNF val66met polymorphism in unmedicated subjects at high genetic risk of schizophrenia performing a verbal memory task. Psychiatry Research 2010, 183:195-201.
4. Banner H., Bhat V., Etchamendy N., Joober R., Bohbot V.D. The brain-derived neurotrophic factor Val66Met polymorphism is associated with reduced functional magnetic resonance imaging activity in the hippocampus and increased use of caudate nucleus-dependent strategies in a human virtual navigation task. European Journal of Neuroscience 2011, 33:968-977.
5. Bekinschtein P., Cammarota M., Igaz L.M., Bevilaqua L.R., Izquierdo I., Medina J.H. Persistence of long-term memory storage requires a late protein synthesis-and BDNF-dependent phase in the hippocampus. Neuron 2007, 53:261-277.
6. Bekinschtein P., Cammarota M., Katche C., Slipczuk L., Rossato J.I., Goldin A., Izquierdo I., Medina J.H. BDNF is essential to promote persistence of long-term memory storage. Proceedings of the National Academy of Sciences 2008, 105:2711.
7. Benjamin S., McQuoid D.R., Potter G.G., Payne M.E., MacFall J.R., Steffens D.C., Taylor W.D. The brain-derived neurotrophic factor Val66Met polymorphism, hippocampal volume, and cognitive function in geriatric depression. American Journal of Geriatric Psychiatry 2010, 18:323-331.
8. Bertolino A., Rubino V., Sambataro F., Blasi G., Latorre V., Fazio L., Caforio G., Petruzzella V., Kolachana B., Hariri A., Meyer-Lindenberg A., Nardini M., Weinberger D.R., Scarabino T. Prefrontal-hippocampal coupling during memory processing is modulated by COMT val158met genotype. Biological Psychiatry 2006, 60:1250-1258.
9. Bliss T.V., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993, 361:31-39. others.
10. Bueller J.A., Aftab M., Sen S., Gomez-Hassan D., Burmeister M., Zubieta J.-K. BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects. Biological Psychiatry 2006, 59:812-815.
11. Callicott J.H., Straub R.E., Pezawas L., Egan M.F., Mattay V.S., Hariri A.R., Verchinski B.A., Meyer-Lindenberg A., Balkissoon R., Kolachana B., Goldberg T.E., Weinberger D.R. Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:8627-8632.
12. Cathomas F., Vogler C., Euler-Sigmund J.C., de Quervain D.J.-F., Papassotiropoulos A. Fine-mapping of the brain-derived neurotrophic factor (BDNF) gene supports an association of the Val66Met polymorphism with episodic memory. International Journal of Neuropsychopharmacology 2010, 13:975-980.
13. Cerasa A., Tongiorgi E., Fera F., Gioia M.C., Valentino P., Liguori M., Manna I., Zito G., Passamonti L., Nisticò R., Quattrone A. The effects of BDNF Val66Met polymorphism on brain function in controls and patients with multiple sclerosis: an imaging genetic study. Behavioural Brain Research 2010, 207:377-386.
14. Chen Z.-Y., Jing D., Bath K.G., Ieraci A., Khan T., Siao C.-J., Herrera D.G., Toth M., Yang C., McEwen B.S., Hempstead B.L., Lee F.S. Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior. Science 2006, 314:140-143.
15. Chepenik L.G., Fredericks C., Papademetris X., Spencer L., Lacadie C., Wang F., Pittman B., Duncan J.S., Staib L.H., Duman R.S., Gelernter J., Blumberg H.P. Effects of the brain-derived neurotrophic growth factor val66met variation on hippocampus morphology in bipolar disorder. Neuropsychopharmacology 2009, 34:944-951.
16. Chung S., Chung H.Y., Jung J., Chang J.K., Hong J.P. Association among aggressiveness, neurocognitive function, and the Val66Met polymorphism of brain-derived neurotrophic factor gene in male schizophrenic patients. Comprehensive Psychiatry 2010, 51:367-372.
17. Cole J., Weinberger D.R., Mattay V.S., Cheng X., Toga A.W., Thompson P.M., Powell-Smith G., Cohen-Woods S., Simmons A., McGuffin P., Fu C.H.Y. No effect of 5HTTLPR or BDNF Val66Met polymorphism on hippocampal morphology in major depression. Genes, Brain and Behavior 2011, 10:756-764.
18. de Quervain D.J., Papassotiropoulos A. Identification of a genetic cluster influencing memory performance and hippocampal activity in humans. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:4270.
19. Dempster E., Toulopoulou T., McDonald C., Bramon E., Walshe M., Filbey F., Wickham H., Sham P.C., Murray R.M., Collier D.A. Association between BDNF val66 met genotype and episodic memory. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2005, 134:73-75.
20. Dempster E., Toulopoulou T., McDonald C., Bramon E., Walshe M., Filbey F., Wickham H., Sham P.C., Murray R.M., Collier D.A. Association between BDNF val66 met genotype and episodic memory. American Journal of Medical Genetics 2005, 134B:73-75.
21. Dennis N.A., Cabeza R., Need A.C., Waters-Metenier S., Goldstein D.B., LaBar K.S. Brain-derived neurotrophic factor val66met polymorphism and hippocampal activation during episodic encoding and retrieval tasks. Hippocampus 2011, 21:980-989.
22. Dutt A., McDonald C., Dempster E., Prata D., Shaikh M., Williams I., Schulze K., Marshall N., Walshe M., Allin M. The effect of COMT, BDNF, 5-HTT, NRG1 and DTNBP1 genes on hippocampal and lateral ventricular volume in psychosis. Psychological Medicine 2009, 39:1783-1797. others.
23. Duval S., Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000, 56:455-463.
24. Easterbrook P.J., Berlin J.A., Gopalan R., Matthews D.R. Publication bias in clinical research. Lancet 1991, 337:867-872.
25. Echeverria D., Woods J.S., Heyer N.J., Rohlman D.S., Farin F.M., Bittner J., Li T., Garabedian C. Chronic low-level mercury exposure, BDNF polymorphism, and associations with cognitive and motor function. Neurotoxicology and Teratology 2005, 27:781-796.
26. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., Zaitsev E., Gold B., Goldman D., Dean M., Lu B., Weinberger D.R. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003, 112:257-269.
27. Egger M., Smith G.D., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. British Medical Journal 1997, 315:629.
28. Ehrlich S., Morrow E.M., Roffman J.L., Wallace S.R., Naylor M., Bockholt H.J., Lundquist A., Yendiki A., Ho B.-C., White T., Manoach D.S., Clark V.P., Calhoun V.D., Gollub R.L., Holt D.J. The COMT Val108/158Met polymorphism and medial temporal lobe volumetry in patients with schizophrenia and healthy adults. Neuroimage 2010, 53:992-1000.
29. Flint J., Munafò M.R. The endophenotype concept in psychiatric genetics. Psychological Medicine 2007, 37:163-180.
30. de Frias C.M., Annerbrink K., Westberg L., Eriksson E., Adolfsson R., Nilsson L.-G. COMT gene polymorphism is associated with declarative memory in adulthood and old age. Behavior Genetics 2004, 34:533-539.
31. Frodl T., Schüle C., Schmitt G., Born C., Baghai T., Zill P., Bottlender R., Rupprecht R., Bondy B., Reiser M., Möller H.-J., Meisenzahl E.M. Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression. Archives of General Psychiatry 2007, 64:410-416.
32. Gasic G.P., Smoller J.W., Perlis R.H., Sun M., Lee S., Kim B.W., Lee M.J., Holt D.J., Blood A.J., Makris N., Kennedy D.K., Hoge R.D., Calhoun J., Fava M., Gusella J.F., Breiter H.C. BDNF, relative preference, and reward circuitry responses to emotional communication. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2009, 150B:762-781.
33. Gatt J.M., Nemeroff C.B., Dobson-Stone C., Paul R.H., Bryant R.A., Schofield P.R., Gordon E., Kemp A.H., Williams L.M. Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety. Molecular Psychiatry 2009, 14:681-695.
34. Gong P., Zheng A., Chen D., Ge W., Lv C., Zhang K., Gao X., Zhang F. Effect of BDNF Val66Met polymorphism on digital working memory and spatial localization in a healthy Chinese Han population. Journal of Molecular Neuroscience 2009, 38:250-256.
35. Gonul A.S., Kitis O., Eker M.C., Eker O.D., Ozan E., Coburn K. Association of the brain-derived neurotrophic factor Val66Met polymorphism with hippocampus volumes in drug-free depressed patients. The World Journal of Biological Psychiatry 2011, 12:110-118.
36. Green M.J., Matheson S.L., Shepherd A., Weickert C.S., Carr V.J. Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis. Molecular Psychiatry 2011, 16:960-972.
37. Gruber O., Hasan A., Scherk H., Wobrock T., Schneider-Axmann T., Ekawardhani S., Schmitt A., Backens M., Reith W., Meyer J., Falkai P. Association of the brain-derived neurotrophic factor val66met polymorphism with magnetic resonance spectroscopic markers in the human hippocampus: in vivo evidence for effects on the glutamate system. European Archives of Psychiatry and Clinical Neuroscience 2012, 262:23-31.
38. Hajek T., Kopecek M., Höschl C. Reduced hippocampal volumes in healthy carriers of brain-derived neurotrophic factor Val66Met polymorphism: meta-analysis. The World Journal of Biological Psychiatry 2012, 13:178-187.
39. Hansell N.K., James M.R., Duffy D.L., Birley A.J., Luciano M., Geffen G.M., Wright M.J., Montgomery G.W., Martin N.G. Effect of the BDNF V166M polymorphism on working memory in healthy adolescents. Genes, Brain and Behavior 2007, 6:260-268.
40. Hariri A.R., Drabant E.M., Weinberger D.R. Imaging genetics: perspectives from studies of genetically driven variation in serotonin function and corticolimbic affective processing. Biological Psychiatry 2006, 59:888-897.
41. Hariri A.R., Goldberg T.E., Mattay V.S., Kolachana B.S., Callicott J.H., Egan M.F., Weinberger D.R. Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. Journal of Neuroscience 2003, 23:6690-6694.
42. Harris S.E., Fox H., Wright A.F., Hayward C., Starr J.M., Whalley L.J., Deary I.J. The brain-derived neurotrophic factor Val66Met polymorphism is associated with age-related change in reasoning skills. Molecular Psychiatry 2006, 11:505-513.
43. Hashimoto R., Moriguchi Y., Yamashita F., Mori T., Nemoto K., Okada T., Hori H., Noguchi H., Kunugi H., Ohnishi T. Dose-dependent effect of the Val66Met polymorphism of the brain-derived neurotrophic factor gene on memory-related hippocampal activity. Neuroscience Research 2008, 61:360-367.
44. Hedges L.V., Olkin I. Statistical Methods for Meta-analysis 1985, others, Academic Press, New York.
45. Hedges L.V., Vevea J.L. Fixed- and random-effects models in meta-analysis. Psychological Methods 1998, 3:486.
46. Heldt S.A., Stanek L., Chhatwal J.P., Ressler K.J. Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories. Molecular Psychiatry 2007, 12:656-670.
47. Higgins J., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. British Medical Journal 2003, 327:557.
48. Ho B.-C., Andreasen N.C., Ziebell S., Pierson R., Magnotta V. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Archives of General Psychiatry 2011, 68:128-137.
49. Ho B.-C., Milev P., O'Leary D.S., Librant A., Andreasen N.C., Wassink T.H. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Archives of General Psychiatry 2006, 63:731-740.
50. Iritani S., Niizato K., Nawa H., Ikeda K., Emson P.C. Immunohistochemical study of brain-derived neurotrophic factor and its receptor, TrkB, in the hippocampal formation of schizophrenic brains. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2003, 27:801-807.
51. Jessen F., Schuhmacher A., von Widdern O., Guttenthaler V., Hofels S., Suliman H., Scheef L., Block W., Urbach H., Maier W., Zobel A. No association of the Val66Met polymorphism of the brain-derived neurotrophic factor with hippocampal volume in major depression. Psychiatric Genetics 2009, 19:99-101.
52. Joffe R.T., Gatt J.M., Kemp A.H., Grieve S., Dobson-Stone C., Kuan S.A., Schofield P.R., Gordon E., Williams L.M. Brain derived neurotrophic factor Val66Met polymorphism, the five factor model of personality and hippocampal volume: implications for depressive illness. Human Brain Mapping 2009, 30:1246-1256.
53. Kanellopoulos D., Gunning F.M., Morimoto S.S., Hoptman M.J., Murphy C.F., Kelly R.E., Glatt C., Lim K.O., Alexopoulos G.S. Hippocampal volumes and the brain-derived neurotrophic factor val66met polymorphism in geriatric major depression. American Journal of Geriatric Psychiatry 2011, 19:13-22.
54. Karnik M.S., Wang L., Barch D.M., Morris J.C., Csernansky J.G. BDNF polymorphism rs6265 and hippocampal structure and memory performance in healthy control subjects. Psychiatry Research 2010, 178:425-429.
55. Kauppi K., Nilsson L.-G., Adolfsson R., Eriksson E., Nyberg L. KIBRA polymorphism is related to enhanced memory and elevated hippocampal processing. Journal of Neuroscience 2011, 31:14218-14222.
56. Koolschijn P.C.M.P., van Haren N.E.M., Bakker S.C., Hoogendoorn M.L.C., Hulshoff Pol H.E., Kahn R.S. Effects of brain-derived neurotrophic factor Val66Met polymorphism on hippocampal volume change in schizophrenia. Hippocampus 2010, 20:1010-1017.
57. Laing K.R., Mitchell D., Wersching H., Czira M.E., Berger K., Baune B.T. Brain-derived neurotrophic factor (BDNF) gene: a gender-specific role in cognitive function during normal cognitive aging of the MEMO-Study?. Age 2011, 1-12.
58. Lau J.Y.F., Goldman D., Buzas B., Hodgkinson C., Leibenluft E., Nelson E., Sankin L., Pine D.S., Ernst M. BDNF gene polymorphism (Val66Met) predicts amygdala and anterior hippocampus responses to emotional faces in anxious and depressed adolescents. Neuroimage 2010, 53:952-961.
59. Li G., Peskind E.R., Millard S.P., Chi P., Sokal I., Yu C.-E., Bekris L.M., Raskind M.A., Galasko D.R., Montine T.J. Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects. PLoS One 2009, 4:e5424.
60. Li S.-C., Chicherio C., Nyberg L., von Oertzen T., Nagel I.E., Papenberg G., Sander T., Heekeren H.R., Lindenberger U., Bäckman L. Ebbinghaus revisited: influences of the BDNF Val66Met polymorphism on backward serial recall are modulated by human aging. Journal of Cognitive Neuroscience 2010, 22:2164-2173.
61. Liu Q.R., Walther D., Drgon T., Polesskaya O., Lesnick T.G., Strain K.J., de Andrade M., Bower J.H., Maraganore D.M., Uhl G.R. Human brain derived neurotrophic factor (BDNF) genes, splicing patterns, and assessments of associations with substance abuse and Parkinson's disease. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2005, 134:93-103.
62. Matsuo K., Walss-Bass C., Nery F.G., Nicoletti M.A., Hatch J.P., Frey B.N., Monkul E.S., Zunta-Soares G.B., Bowden C.L., Escamilla M.A., Soares J.C. Neuronal correlates of brain-derived neurotrophic factor Val66Met polymorphism and morphometric abnormalities in bipolar disorder. Neuropsychopharmacology 2009, 34:1904-1913.
63. McClearn G.E., Johansson B., Berg S., Pedersen N.L., Ahern F., Petrill S.A., Plomin R. Substantial genetic influence on cognitive abilities in Twins 80 or more years old. Science 1997, 276:1560-1563.
64. Milner B., Squire L.R., Kandel E.R. Cognitive neuroscience and the study of memory. Neuron 1998, 20:445-468.
65. Miyajima F., Ollier W., Mayes A., Jackson A., Thacker N., Rabbitt P., Pendleton N., Horan M., Payton A. Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly. Genes, Brain and Behavior 2008, 7:411-417.
66. Mizuno M., Yamada K., Olariu A., Nawa H., Nabeshima T. Involvement of brain-derived neurotrophic factor in spatial memory formation and maintenance in a radial arm maze test in rats. Journal of Neuroscience 2000, 20:7116.
67. Montag C., Reuter M., Newport B., Elger C., Weber B. The BDNF Val66Met polymorphism affects amygdala activity in response to emotional stimuli: evidence from a genetic imaging study. NeuroImage 2008, 42:1554-1559.
68. Montag C., Weber B., Fliessbach K., Elger C., Reuter M. The BDNF Val66Met polymorphism impacts parahippocampal and amygdala volume in healthy humans: incremental support for a genetic risk factor for depression. Psychological Medicine 2009, 39:1831-1839.
69. Muglia P., Vicente A.M., Verga M., King N., Macciardi F., Kennedy J.L. Association between the BDNF gene and schizophrenia. Molecular Psychiatry 2003, 8:146-147.
70. Munafò M.R., Brown S.M., Hariri A.R. Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis. Biological Psychiatry 2008, 63:852-857.
71. Murer M.G., Yan Q., Raisman-Vozari R. Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Progress in Neurobiology 2001, 63:71-124.
72. Nanko S., Kunugi H., Hirasawa H., Kato N., Nabika T., Kobayashi S. Brain-derived neurotrophic factor gene and schizophrenia: polymorphism screening and association analysis. Schizophrenia Research 2003, 62:281-283.
73. Nemoto K., Ohnishi T., Mori T., Moriguchi Y., Hashimoto R., Asada T., Kunugi H. The Val66Met polymorphism of the brain-derived neurotrophic factor gene affects age-related brain morphology. Neuroscience Letters 2006, 397:25-29.
74. Ozan E., Okur H., Eker C., Eker O.D., Gönül A.S., Akarsu N. The effect of depression, BDNF gene val66met polymorphism and gender on serum BDNF levels. Brain Research Bulletin 2010, 81:61-65.
75. Pang P.T., Teng H.K., Zaitsev E., Woo N.T., Sakata K., Zhen S., Teng K.K., Yung W.H., Hempstead B.L., Lu B. Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science 2004, 306:487.
76. Papassotiropoulos A., Stephan D.A., Huentelman M.J., Hoerndli F.J., Craig D.W., Pearson J.V., Huynh K.-D., Brunner F., Corneveaux J., Osborne D., Wollmer M.A., Aerni A., Coluccia D., Hänggi J., Mondadori C.R.A., Buchmann A., Reiman E.M., Caselli R.J., Henke K., de Quervain D.J.-F. Common Kibra alleles are associated with human memory performance. Science 2006, 314:475-478.
77. Pastalkova E., Serrano P., Pinkhasova D., Wallace E., Fenton A.A., Sacktor T.C. Storage of spatial information by the maintenance mechanism of LTP. Science 2006, 313:1141.
78. Peper J.S., Brouwer R.M., Boomsma D.I., Kahn R.S., Hulshoff Pol H.E. Genetic influences on human brain structure: a review of brain imaging studies in twins. Human Brain Mapping 2007, 28:464-473.
79. Peters J.L., Sutton A.J., Jones D.R., Abrams K.R., Rushton L. Performance of the trim and fill method in the presence of publication bias and between-study heterogeneity. Statistics in medicine 2007, 26:4544-4562.
80. Pezawas L., Verchinski B.A., Mattay V.S., Callicott J.H., Kolachana B.S., Straub R.E., Egan M.F., Meyer-Lindenberg A., Weinberger D.R. The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. Journal of Neuroscience 2004, 24:10099-10102.
81. Pezawas L., Meyer-Lindenberg A., Goldman A.L., Verchinski B.A., Chen G., Kolachana B.S., Egan M.F., Mattay V.S., Hariri A.R., Weinberger D.R. Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression. Molecular Psychiatry 2008, 13:709-716.
82. Raz N., Dahle C.L., Rodrigue K.M., Kennedy K.M., Land S.J., Jacobs B.S. Brain-derived neurotrophic factor Val66Met and blood glucose: a synergistic effect on memory. Frontiers in Human Neuroscience 2008, 2:12.
83. R Development Core Team R: A language and environment for statistical computing 2012, R Foundation for Statistical Computing, Vienna, Austria. http://www.r-project.org/.
84. Reichardt L.F. Neurotrophin-regulated signalling pathways. Philosophical Transactions of the Royal Society B: Biological Sciences 2006, 361:1545.
85. Richter-Schmidinger T., Alexopoulos P., Horn M., Maus S., Reichel M., Rhein C., Lewczuk P., Sidiropoulos C., Kneib T., Perneczky R., Doerfler A., Kornhuber J. Influence of brain-derived neurotrophic-factor and apolipoprotein E genetic variants on hippocampal volume and memory performance in healthy young adults. Journal of Neural Transmission 2011, 118:249-257.
86. Riedel M., Schennach-Wolff R., Musil R., Dehning S., Cerovecki A., Opgen-Rhein M., Matz J., Seemüller F., Obermeier M., Engel R.R., Müller N., Möller H.-J., Spellmann I. Neurocognition and its influencing factors in the treatment of schizophrenia-effects of aripiprazole, olanzapine, quetiapine and risperidone. Human Psychopharmacology 2010, 25:116-125.
87. Rybakowski J.K., Borkowska A., Czerski P.M., Skibińska M., Hauser J. Polymorphism of the brain-derived neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients. Bipolar Disorders 2003, 5:468-472.
88. Rybakowski J.K., Borkowska A., Skibinska M., Hauser J. Illness-specific association of val66met BDNF polymorphism with performance on Wisconsin Card Sorting Test in bipolar mood disorder. Molecular Psychiatry 2006, 11:122-124.
89. Sambataro F., Murty V.P., Lemaitre H.S., Reed J.D., Das S., Goldberg T.E., Callicott J.H., Weinberger D.R., Mattay V.S. BDNF modulates normal human hippocampal ageing [corrected]. Molecular Psychiatry 2010, 15:116-118.
90. Schofield P.R., Williams L.M., Paul R.H., Gatt J.M., Brown K., Luty A., Cooper N., Grieve S., Dobson-Stone C., Morris C., Kuan S.A., Gordon E. Disturbances in selective information processing associated with the BDNF Val66Met polymorphism: evidence from cognition, the P300 and fronto-hippocampal systems. Biological Psychology 2009, 80:176-188.
91. Smieskova R., Fusar-Poli P., Allen P., Bendfeldt K., Stieglitz R.D., Drewe J., Radue E.W., McGuire P.K., Riecher-Rössler A., Borgwardt S.J. The effects of antipsychotics on the brain: what have we learnt from structural imaging of schizophrenia?.--a systematic review. Current Pharmaceutical Design 2009, 15:2535-2549.
92. Soliman F., Glatt C.E., Bath K.G., Levita L., Jones R.M., Pattwell S.S., Jing D., Tottenham N., Amso D., Somerville L.H., Voss H.U., Glover G., Ballon D.J., Liston C., Teslovich T., Van Kempen T., Lee F.S., Casey B.J. A genetic variant BDNF polymorphism alters extinction learning in both mouse and human. Science 2010, 327:863-866.
93. Stern A.J., Savostyanova A.A., Goldman A., Barnett A.S., van der Veen J.W.C., Callicott J.H., Mattay V.S., Weinberger D.R., Marenco S. Impact of the brain derived neurotrophic factor Val66Met polymorphism on levels of hippocampal N-acetyl aspartate assessed by magnetic resonance spectroscopic imaging at 3 Tesla. Biological Psychiatry 2008, 64:856-862.
94. Strauss J., Barr C.L., George C.J., King N., Shaikh S., Devlin B., Kovacs M., Kennedy J.L. Association study of brain-derived neurotrophic factor in adults with a history of childhood onset mood disorder. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2009, 131:16-19.
95. Strauss J., Barr C.L., George C.J., Ryan C.M., King N., Shaikh S., Kovacs M., Kennedy J.L. BDNF and COMT polymorphisms: relation to memory phenotypes in young adults with childhood-onset mood disorder. Neuromolecular Medicine 2004, 5:181-192.
96. Sublette M.E., Baca-Garcia E., Parsey R.V., Oquendo M.A., Rodrigues S.M., Galfalvy H., Huang Y.-Y., Arango V., Mann J.J. Effect of BDNF val66met polymorphism on age-related amygdala volume changes in healthy subjects. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2008, 32:1652-1655.
97. Szeszko P.R., Lipsky R., Mentschel C., Robinson D., Gunduz-Bruce H., Sevy S., Ashtari M., Napolitano B., Bilder R.M., Kane J.M., Goldman D., Malhotra A.K. Brain-derived neurotrophic factor val66met polymorphism and volume of the hippocampal formation. Molecular Psychiatry 2005, 10:631-636.
98. Takahashi T., Suzuki M., Tsunoda M., Kawamura Y., Takahashi N., Tsuneki H., Kawasaki Y., Zhou S.-Y., Kobayashi S., Sasaoka T., Seto H., Kurachi M., Ozaki N. Association between the brain-derived neurotrophic factor Val66Met polymorphism and brain morphology in a Japanese sample of schizophrenia and healthy comparisons. Neuroscience Letters 2008, 435:34-39.
99. Tamminga C.A., Stan A.D., Wagner A.D. The hippocampal formation in schizophrenia. American Journal of Psychiatry 2010, 167:1178-1193.
100. Tan H.Y., Chen A.G., Chen Q., Browne L.B., Verchinski B., Kolachana B., Zhang F., Apud J., Callicott J.H., Mattay V.S., Weinberger D.R. Epistatic interactions of AKT1 on human medial temporal lobe biology and pharmacogenetic implications. Molecular Psychiatry 2011, 1-10.
101. Tan Y.L., Zhou D.F., Cao L.Y., Zou Y.Z., Wu G.Y., Zhang X.Y. Effect of the BDNF Val66Met genotype on episodic memory in schizophrenia. Schizophrenia Research 2005, 77:355-356.
102. Thomason M.E., Yoo D.J., Glover G.H., Gotlib I.H. BDNF genotype modulates resting functional connectivity in children. Frontiers in Human Neuroscience 2009, 3:55.
103. Toro R., Chupin M., Garnero L., Leonard G., Perron M., Pike B., Pitiot A., Richer L., Veillette S., Pausova Z., Paus T. Brain volumes and Val66Met polymorphism of the BDNF gene: local or global effects?. Brain Structure and Function 2009, 213:501-509.
104. Torres I.J., Boudreau V.G., Yatham L.N. Neuropsychological functioning in euthymic bipolar disorder: a meta-analysis. Acta Psychiatrica Scandinavica. Supplementum 2007, 17-26.
105. Varnäs K., Lawyer G., Jönsson E.G., Kulle B., Nesvåg R., Hall H., Terenius L., Agartz I. Brain-derived neurotrophic factor polymorphisms and frontal cortex morphology in schizophrenia. Psychiatric Genetics 2008, 18:177-183.
106. Viechtbauer W. Conducting meta-analyses in R with the metafor package. Journal of Statistical Software 2010, 36:1-48.
107. Voineskos A.N., Lerch J.P., Felsky D., Shaikh S., Rajji T.K., Miranda D., Lobaugh N.J., Mulsant B.H., Pollock B.G., Kennedy J.L. The brain-derived neurotrophic factor Val66Met polymorphism and prediction of neural risk for Alzheimer disease. Archives of General Psychiatry 2011, 68:198-206.
108. van Wingen G., Rijpkema M., Franke B., van Eijndhoven P., Tendolkar I., Verkes R.J., Buitelaar J., Fernández G. The brain-derived neurotrophic factor Val66Met polymorphism affects memory formation and retrieval of biologically salient stimuli. NeuroImage 2010, 50:1212-1218.
109. Yan Q., Rosenfeld R.D., Matheson C.R., Hawkins N., Lopez O.T., Bennett L., Welcher A.A. Expression of brain-derived neurotrophic factor protein in the adult rat central nervous system. Neuroscience 1997, 78:431-448.
110. Zivadinov R., Weinstock-Guttman B., Benedict R., Tamaño-Blanco M., Hussein S., Abdelrahman N., Durfee J., Ramanathan M. Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor. Human Molecular Genetics 2007, 16:2659-2668.